LHC Group

LHC Group is a holding company. Through its subsidiaries, the company provides post-acute health care services to its patients. The company's segments include: home health services, which include nursing, medically-oriented social services and physical, occupational, and speech therapy; hospice services, which include pain and symptom management, emotional and spiritual support, inpatient and respite care, homemaker services, dietary counseling, and family bereavement counseling; and home and community-based services, which include assistance with grooming, medication reminders, meal preparation, assistance with feeding, light housekeeping, respite care, transportation, and errand services.
  • TickerLHCG
  • ISINUS50187A1079
  • ExchangeNASDAQ Stock Market
  • SectorHealth Care Equipment & Services
  • CountryUnited States

LHC Group Inc: 1 director

A director at LHC Group Inc sold 5,000 shares at 201.620USD and the significance rating of the trade was 72/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showing Close periods where trading activity is restricted under listing rules. The names of board ...

LHC GROUP sees an upgrade to Slightly Positive due to a better fundamental star rating

The general evaluation of LHC GROUP (US), a company active in the Health Care Providers industry, has been upgraded by the independent financial analyst theScreener with the addition of a star. Its fundamental valuation now shows 1 out of 4 possible stars while its market behaviour can be considered as defensive. theScreener believes that the additional star(s) merits the upgrade of its general evaluation to Slightly Positive. As of the analysis date February 26, 2021, the closing price was USD 181.71 and its potential was estimated at USD 248.98.

MarketLine Department

Evolent Health Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances And Investments

Summary Marketline's Evolent Health Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by Evolent Health Inc since January2007. Marketline's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. ...

Dave Nicoski ...
  • Ross LaDuke

Vital Signs: Actionable charts

Key Points: • A number of names in the Communications Sector are showing signs of leadership. (ex. GLUU, TWTR, GOOGL, NYT, and NWSA) • Consumer Discretionary continues to have a number of attractive names technically. (ex. TPR, LGIH, DHI, VSTO, RGR, PENN, SGMS, BYD, BJRI, BKE, EBAY, SIG, HAIN, and ENR ) • A number of Financial Sector names appear to be perking up. (ex. JHG, INTL, EVR, GHL, ARR, and CINF)

Dave Nicoski ...
  • Ross LaDuke

Vermilion Compass: Weekly Equity Strategy

Deterioration beneath the surface In last week's Compass we highlighted several cyclical areas of the market that were at or near support - areas we often look to in order to gauge risk sentiment. We posited that if support levels hold we could be looking at a pullback similar to that of May, but that breakdowns would likely lead to a deeper correction similar to October and/or December of 2018. Support levels held for the majority of these cyclical areas of the market, but not all. Below we highlight these and other concerning developments which show that there is some deterioration beneath ...

Dave Nicoski ...
  • Ross LaDuke

Vital Signs: Actionable charts

Key Points: • Health Care remains a bright spot and many individual names are breaking to RS highs. • Many Consumer Cyclical names such as NKE and CMG are emerging as leadership. • Many Semi and Semiconductor supplier names are staging Price and RS reversals.

Dave Nicoski ...
  • Ross LaDuke

Vital Signs: Actionable charts

Key Points: • Emerging markets are attempting a reversal. We believe this would be a positive sign for the U.S markets and the Materials Sector. • Starbucks and a number of restaurant stocks are developing positively. • Chemical stocks are near breakouts or attempting to stage price and RS reversals.

LHC Group Inc: 1 director

A director at LHC Group Inc sold 5,000 shares at 201.620USD and the significance rating of the trade was 72/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showing Close periods where trading activity is restricted under listing rules. The names of board ...

MarketLine Department

Evolent Health Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances And Investments

Summary Marketline's Evolent Health Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by Evolent Health Inc since January2007. Marketline's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. ...

MarketLine Department

Civitas Solutions Inc - Strategy, SWOT and Corporate Finance Report

Summary Civitas Solutions Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Highlights Civitas Solutions Inc (Civitas), formerly NMH Holdings Inc is a provider of home and community-based health and human services in the US. It offers services to adults and children with intellectual and developmental disabilities, brain and spinal cord injuries and other catastrophic in...

Dave Nicoski ...
  • Ross LaDuke

Vital Signs: Actionable charts

In this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patterns that may have long-term significance, etc. We believe you will find this product valuable as significant price and relative moves begin in the daily charts.

Dave Nicoski ...
  • Ross LaDuke

Vital Signs: Actionable charts

In this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patterns that may have long-term significance, etc. We believe you will find this product valuable as significant price and relative moves begin in the daily charts.

LHC GROUP sees an upgrade to Slightly Positive due to a better fundamental star rating

The general evaluation of LHC GROUP (US), a company active in the Health Care Providers industry, has been upgraded by the independent financial analyst theScreener with the addition of a star. Its fundamental valuation now shows 1 out of 4 possible stars while its market behaviour can be considered as defensive. theScreener believes that the additional star(s) merits the upgrade of its general evaluation to Slightly Positive. As of the analysis date February 26, 2021, the closing price was USD 181.71 and its potential was estimated at USD 248.98.

ResearchPool Subscriptions

Get the most out of your insights

Get in touch